Clinical Trial Update: AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock [Phase 2]

View source ↗

Summary

Phase 2 trial update for AVERT Shock study investigating Arginine Vasopressin during early resuscitation of traumatic shock; study completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Shock

Drugs mentioned

• Arginine-vasopressin (arginine vasopressin)

Snippet

Sponsor: University of Pennsylvania | Conditions: Traumatic Shock | Phase 2 | Status: COMPLETED | Results posted: 2019-05-21